Wolverine Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-57,333
Closed -$2.14M 2412
2022
Q2
$2.14M Buy
57,333
+20,346
+55% +$828K 0.03% 536
2022
Q1
$1.64M Buy
36,987
+17,094
+86% +$741K 0.02% 573
2021
Q4
$845K Buy
+19,893
New +$836K 0.01% 852
2021
Q3
Sell
-12,402
Closed -$530K 2027
2021
Q2
$530K Sell
12,402
-11,026
-47% -$464K 0.01% 879
2021
Q1
$905K Sell
23,428
-342,825
-94% -$13M 0.01% 686
2020
Q4
$13.2M Buy
366,253
+306,430
+512% +$11M 0.13% 168
2020
Q3
$2.29M Buy
59,823
+59,269
+10,698% +$2.28M 0.03% 379
2020
Q2
$19K Buy
+554
New +$20K ﹤0.01% 1368
2019
Q2
Sell
-2,902
Closed -$111K 1429
2019
Q1
$111K Buy
+2,902
New +$111K ﹤0.01% 1105
2017
Q2
Hold
0
1296
2017
Q1
Hold
0
1208
2014
Q4
Hold
0
2245
2014
Q3
Sell
-4,700
Closed -$59.2K 2494
2014
Q2
$60K Buy
+4,700
New +$61.1K ﹤0.01% 1318
2014
Q1
Sell
-30,000
Closed -$394K 2483
2013
Q4
$360K Sell
30,000
-100
-0.3% -$1.18K 0.01% 900
2013
Q3
$353K Buy
30,100
+29,100
+2,910% +$315K 0.01% 898
2013
Q2
$9K Buy
+1,000
New +$8.48K ﹤0.01% 2231

Other funds holding BSX